Subconjunctival Bevacizumab and Recurrent Pterygium
NCT01744756
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Pterygium
Interventions
DRUG:
Bevacizumab
Sponsor
Instituto de Olhos de Goiania